Celldex Therapeutics Inc <CLDX.O>: Morgan Stanley cuts target price to $40.00 from $44.00
CLDX•Related News
Cognyte names Adam Philpott chief revenue officer as Efi Nuri retires
CGNT•
High-Trend net loss narrows to $3.52 million in 6 months ended April 30, 2026; revenue rises to $137.45 million
HTCO•
Veeco updates financial calendar with second-quarter 2026 results release, conference call
VECO•
Gold climbs to two-week high as investors watch Middle East conflict
GLD•
Wabash partners with Truck Source to expand Western U.S. dealer network
WNC•